To determine whether the observations made in mouse cells were also seen in human cells, we isolated PBMCs of AML, JMML or CMML patients with KRAS mutations (Krasmut) and gated on CD11b+ cells (Supplementary Fig. S5A). Here, KRAS is linked to juvenile myelomonocytic leukemia.